HSE enter 'final stages' of talks for Cystic Fibrosis drug Orkambi

The HSE will today enter the 'final stages' of talks to agree the price of a major new drug for Cystic Fibrosis.
Senior management will spend the rest of the week in discussions with Vertex over the cost of the drug Orkambi.